Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy

Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy

US Patent 12285497 · Granted Apr 29, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adeno-associated virus vector delivery of muscle specific micro-dystrophin to tr2025
Adeno-associated virus vector delivery of muscle specific micro-dystrophin to tr2025
Guide RNA for repairing a mutant human titin gene using CRISPR technology2025
Adeno-associated virus antibodies and fragments thereof2025
Adeno-associated virus vector delivery of β-sarcoglycan and the treatment of mus2025
Adeno-associated virus vector delivery of β-sarcoglycan and the treatment of mus2025
Gene therapy for limb-girdle muscular dystrophy type 2C2025
Adeno-associated virus vector delivery of alpha-sarcoglycan and the treatment of2025
Adeno-associated virus vector delivery of alpha-sarcoglycan and the treatment of2025
Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan 2024
Methods of treating muscular dystrophy2023
Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dys2023